SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) - Stock analysts at Sidoti Csr decreased their Q1 2025 EPS estimates for SBC Medical Group in a research report issued to clients and investors on Monday, March 31st. Sidoti Csr analyst A. Shah now expects that the company will post earnings of $0.15 per share for the quarter, down from their prior forecast of $0.16. The consensus estimate for SBC Medical Group's current full-year earnings is $5.02 per share. Sidoti Csr also issued estimates for SBC Medical Group's Q2 2025 earnings at $0.13 EPS, Q3 2025 earnings at $0.14 EPS, Q4 2025 earnings at $0.11 EPS, FY2025 earnings at $0.54 EPS, Q1 2026 earnings at $0.16 EPS, Q2 2026 earnings at $0.15 EPS, Q3 2026 earnings at $0.15 EPS, Q4 2026 earnings at $0.14 EPS and FY2026 earnings at $0.61 EPS.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last issued its quarterly earnings data on Friday, March 28th. The company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.01. The company had revenue of $57.90 million for the quarter, compared to analysts' expectations of $56.34 million.
SBC Medical Group Stock Performance
Shares of SBC stock traded up $0.12 during mid-day trading on Tuesday, hitting $3.29. 13,984 shares of the stock traded hands, compared to its average volume of 58,141. SBC Medical Group has a 52-week low of $2.62 and a 52-week high of $12.50. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.76 and a current ratio of 2.79. The stock's fifty day moving average price is $4.22.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Featured Stories
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
